Triblend 2mg/500mg/15mg Tablet SR
Marketer
Akesiss Pharma Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Triblend 2mg/500mg/15mg Tablet SR
Combiflex SR tablets (2mg/500mg/15mg) are a triple-action formulation designed to manage blood glucose. This medication, used in conjunction with a healthy diet and regular exercise, enhances glycemic control in adults diagnosed with type 2 diabetes. It facilitates improved insulin utilization, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflex SR. Ingestion with food is recommended to mitigate potential gastrointestinal discomfort. If a dose is missed, take it promptly; however, if nearing the next scheduled dose, omit the missed dose and resume the regular schedule. Never double the dose. An overdose can result in hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Commonly reported adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before initiating therapy. Kidney function assessment will be conducted before treatment begins. Limit alcohol consumption while taking this medication to minimize the risk of side effects.
Uses of Triblend 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Triblend 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. The Triblend 2mg/500mg/15mg Extended-Release tablet should be taken with a meal.
Common Side effects of Triblend 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triblend 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Triblend 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Triblend 2mg/500mg/15mg Tablet SR works:
Triblend 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this by further augmenting insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Triblend 2mg/500mg/15mg SR tablets is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Triblend 2mg/500mg/15mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Triblend tablets (2mg/500mg/15mg) are likely not suitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk with consequent risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Triblend 2mg/500mg/15mg SR tablets to individuals with impaired kidney function. Dosage modification of Triblend 2mg/500mg/15mg SR tablets may be necessary; physician consultation is advised. Triblend 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Triblend 2mg/500mg/15mg SR tablets; dosage modification may be necessary. Consult a physician for guidance. Triblend 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Triblend 2mg/500mg/15mg Tablet SR :
Should you forget to take your Triblend 2mg/500mg/15mg SR tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triblend 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Medication for diabetes |
3,018 People bought this recently